SSRM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SSRM is not a strong buy at the moment for a beginner investor with a long-term strategy. Despite positive technical indicators and some bullish analyst ratings, the company's recent financial performance is weak, hedge funds are selling, and there is no strong proprietary trading signal. The investor may consider holding off for now or exploring other opportunities.
The MACD is positive and expanding, indicating bullish momentum. The RSI is neutral at 77, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at 31.578 and 33.265, while support levels are at 26.115 and 24.428. The stock has an 80% chance to increase 6.1% in the next month.
Some analysts have raised price targets, with UBS and TD Securities maintaining Buy ratings. The stock is expected to increase in the next month based on historical patterns.
Hedge funds are selling heavily, with a 763.19% increase in selling over the last quarter. The company's financial performance in Q4 2025 was poor, with a significant drop in net income, EPS, and gross margin. No recent congress trading data or influential figure activity.
In Q4 2025, revenue increased by 119.61% YoY to $709.76M. However, net income dropped drastically to -$181.46M (-3366.55% YoY), EPS fell to 0 (-100% YoY), and gross margin dropped to 0 (-100% YoY).
Analyst ratings are mixed. UBS and TD Securities maintain Buy ratings with price targets of $37 and C$43, respectively. BofA has an Underperform rating with a price target of $23, citing concerns over the company's valuation and project updates.
